RBA-004

N/A

Report date: 2025/06/11 10:38:58

Base Information

Drug NameRBA-004

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionSignal transducer and activator of transcription 3 inhibitors

TargetsSignal transducer and activator of transcription 3

Therapy Area/IndicationsInflammationNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesRophibio Inc

China Registration ClassN/A

Develop Information

Active CompaniesRophibio Inc

Inactive CompaniesN/A

Active IndicationsInflammationNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A